Inhibition of IL-8 release from CFTR-deficient lung epithelial cells following pre-treatment with fenretinide

International Immunopharmacology

Volumn 6, Issue 11, 2006, Pages 1651-1664

  Vilela, Regina Maria ^a   Lands, Larry C ^b   Meehan, Brian ^b   Kubow, Stan ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

Ceramide; Cystic fibrosis; Fenretinide; Glutathione; Interleukin 8; Tumor necrosis factor alpha

Indexed keywords

CERAMIDE; CISPLATIN; FENRETINIDE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; TRANSCRIPTION FACTOR; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LUNG ALVEOLUS EPITHELIUM; PNEUMONIA; PRIORITY JOURNAL; SECOND MESSENGER; TRACHEA MUCOSA;

ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE; CELL PROLIFERATION; CERAMIDES; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL CELLS; FENRETINIDE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HUMANS; INTERLEUKIN-8; TRACHEA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33748623080     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.06.012     Document Type: Article

References (63)

1. Dinwiddie R. Pathogenesis of lung disease in cystic fibrosis. Respiration 67 (2000) 3-8
2. Bals R., Weiner D.J., and Wilson J.M. The innate immune system in cystic fibrosis lung disease. J Clin Invest 103 (1999) 303-307
3. Knowles M.R., and Boucher R.C. Mucus clearance as a primary innate defense mechanism for mammalian airways ("Perspective"). J Clin Invest 109 (2002) 571-577
4. Venkatakrishman A., Stecenko A.A., King G., Blackwell T.R., Brigham K.L., Christman J.W., et al. Exaggerated activation of nuclear factor-κB and altered IκB-β processing in cystic fibrosis bronchial epithelial cells. Am J Respir Cell Mol 23 (2000) 1-16
5. Stecenko A.A., King G., Torii K., Breyer R.M., Dworski R., Blackwell T.S., et al. Dysregulated cytokine production in human cystic fibrosis bronchial epithelial cells. Inflammation 25 (2001) 145-155
6. Becker M.N., Sauer M.S., Muhlebach M.S., Hirsh A.J., Wu Q., Verghese M.W., et al. Cytokine secretion by cystic fibrosis airway epithelial cells. Am J Respir Crit Care 169 (2004) 645-653
7. Signorelli P., Luberto C., and Hannun Y.A. Ceramide inhibition of NF-kappaB activation involves reverse translocation of classical protein kinase C (PKC) isoenzymes: requirement for kinase activity and carboxyl-terminal phosphorylation of PKC for the ceramide response. FASEB J 15 (2001) 2401-2414
8. Hannun Y.A. Functions of ceramide in coordinating cellular responses to stress. Science 274 (1996) 1855-1859
9. Levade T., and Jaffrezou J.P. Signalling sphingomyelinases: which, where, how and why. Biochim Biophys Acta 1438 (1999) 1-17
10. Chan C., and Goldkorn T. Ceramide path in human lung cell death. Am J Respir Cell Mol 22 (2000) 460-468
11. Liu B., Andrieu-Abadie N., Levade T., Zhang P., Obeid L.M., and Hannun Y.A. Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death. J Biol Chem 273 (1998) 11313-11320
12. Luberto C., Yoo D.S., Suidan H.S., Bartoli G.M., and Hannun Y.A. Differential effects of sphingomyelin hydrolysis and resynthesis on the activation of NF-kappa B in normal and SV40-transformed human fibroblasts. J Biol Chem 275 (2000) 14760-14766
13. Beaver J.P., and Waring P. A decrease in intracellular glutathione concentration precedes the onset of apoptosis in murine thymocytes. Eur J Cell Biol 68 (1995) 47-54
14. Singh I., Pahan K., Khan M., and Singh A.K. Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. J Biol Chem 273 (1998) 20354-20362
15. Lavrentiadou S.N., Chan C., Kawcak T., Ravid T., Tsaba A., van der Vliet A., et al. Ceramide-mediated apoptosis in lung epithelial cells is regulated by glutathione. Am J Respir Cell Mol 25 (2001) 676-684
16. Linsdell P., and Hanrahan J.W. Glutathione permeability of CFTR. Am J Physiol 275 (1998) C323-C326
17. Jungas T., Motta I., Duffieux F., Fanen P., Stoven V., and Ojcius D.M. Glutathione levels and BAX activation during apoptosis due to oxidative stress in cells expressing wild-type and mutant cystic fibrosis transmembrane conductance regulator. J Biol Chem 277 (2002) 27912-27918
18. Cannon C.L., Kowalski M.P., Stopak K.S., and Pier G.B. Pseudomonas aeruginosa-induced apoptosis is defective in respiratory epithelial cells expressing mutant cystic fibrosis transmembrane conductance regulator. Am J Respir Cell Mol 29 (2003) 188-197
19. Ulukaya E., and Wood E.J. Fenretinide and its relation to cancer. Cancer Treat Rev 25 (1999) 229-235
20. Erdreich-Epstein A., Tran L.B., Bowman N.N., Wang H., Cabot M.C., Durden D.L., et al. Ceramide signaling in fenretinide-induced endothelial cell apoptosis. J Biol Chem 277 (2002) 49531-49537
21. Shimada K., Nakamura M., Ishida E., Kishi M., Yonehara S., and Konishi N. Contributing of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl) retinamide-induced apoptosis in prostate cancer cells. Mol Carcinog 35 (2002) 127-137
22. Cuello M., Coats A.O., Darko I., Ettenberg S.A., Gardner G.J., Nau M.M., et al. N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell lines. Cell Death Differ 11 (2004) 527-541
23. Wang H., Maurer B.J., Reynolds C.P., and Cabot M.C. N-(4-hydroxyphenyl) retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase. Cancer Res 61 (2001) 5102-5105
24. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-63
25. van de Loosdrecht A.A., Beelen R.H., Ossenkoppele G.J., Broekhoven M.G., and Langenhuijsen M.M. Tetrazolium-based mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leucemia. J Immunol Methods 174 (1994) 311-320
26. Dbaibo G.S., Perry D.K., Gamard C.J., Platt R., Poirier G.G., Obeid L.M., et al. Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-α: CrmA and Bcl-2 target distinct components in the apoptotic pathway. J Exp Med 185 (1997) 481-490
27. I. Ginis, U. Schweizer, M. Brenner, J. Liu, N. Azzam, M. Spatz et al., TNF-α pretreatment prevents subsequent activation of cultured brain cells with TNF-α and hypoxia via ceramide, Am J Physiol 276 (Cell Physiol 45) (1999), C1171-C1183.
28. Zimmermann C., Ginis I., Furuya K., Klimanis D., Ruetzler C., and Spatz M. Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma. Brain Res 895 (2001) 59-65
29. Anderson M.E. Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol 113 (1985) 548-551
30. Schwiebert L.M., Estell K., and Propst S.M. Chemokine expression in CF epithelia: implications for the role of CFTR in RANTES expression. Am J Physiol 276 (1999) C700-C710
31. Tabary O., Zahm J.M., Hinnrasky J., Couetil J.P., Cornillet P., Guenounou M., et al. Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro. Am J Pathol 153 (1998) 921-930
32. Bedard M., McClure C.D., Schiller N.L., Francoeur C., Cantin A., and Denis M. Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis. Am J Respir Cell Mol 9 (1993) 455-462
33. Massengale A.R., Quinn Jr. F., Yankaskas J., Weissman D., McClellan W.T., Cuff C., et al. Reduced interleukin-8 production by cystic fibrosis airway epithelial cells. Am J Respir Cell Mol 20 (1999) 1073-1080
34. Garaventa A., Luksch R., Lo Piccolo M.S., Cavadini E., Montaldo P.G., Pizzitola M.R., et al. Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma. Clin Cancer Res 9 (2003) 2032-2039
35. Maurer B.J., Metelitsa L.S., Seeger R.C., Cabot M.C., and Reynolds C.P. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)-retinamide in neuroblastoma cell lines. J Natl Cancer I 91 (1999) 1138-1146
36. Hannun Y.A., and Bell R.M. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science 243 (1989) 500-507
37. Mallampalli R.K., Peterson E.J., Carter A.B., Salome R.G., Mathur S.N., and Koretzky G.A. TNF-alpha increases ceramide without inducing apoptosis in alveolar type II epithelial cells. Am J Physiol 276 (1999) L481-L490
38. Boujaoude L.C., Bradshaw-Wilder C., Mao C., Cohn J., Ogretmen B., Hannun Y.A., et al. Cystic fibrosis transmembrane regulator regulates uptake of sphingoid base phosphates and lysophosphatidic acid. Modulation of cellular activity of sphingosine 1-phosphate. J Biol Chem 276 (2001) 35258-35264
39. Merritt G., Aliprandis E.T., Prada F., Rigas B., and Kashfi K. The retinoid fenretinide inhibits proliferation and downregulates cyclooxygenase-2 gene expression in human colon adenocarcinoma cell lines. Cancer Lett 164 (2001) 15-23
40. Freedman S.D., Blanco P.G., Zaman M.M., Shea J.L., Ollero M., Hopper I.K., et al. Association of cystic fibrosis with abnormalities in fatty acid metabolism. New Engl J Med 350 (2004) 560-569
41. Gao L., Kim K.J., Yankaskas J.R., and Forman H.J. Abnormal glutathione transport in cystic fibrosis airway epithelia. Am J Physiol 277 (1999) L113-L118
42. In: Groff J.L., and Gropper S.S. (Eds). Advanced nutrition and human metabolism (2000), Belmont: West/Wadsworth, San Francisco, CA
43. In: Peters Jr. T. (Ed). All about albumin: biochemistry, genetics, and medical applications (1996), Academic Press Inc, San Diego, CA
44. Shaw J.P., and Chou I.N. Elevation of extracellular glutathione content associated with mitogenic stimulation of quiescent fibroblast. J Cell Physiol 129 (1986) 193-198
45. Kang Y.-J., and Enger M.D. Increased glutathione levels in quiescent, serum-stimulated NRK-49F cells are associated not with a response to growth factors but with nutrient repletion. J Cell Physiol 148 (1991) 197-201
46. Rahman I., Biswas S.K., Jimenez L.A., Torres M., and Forman H.J. Glutathione, stress responses, and redox signaling in lung inflammation. Antioxid Redox Signal 7 (2005) 42-59
47. Andrieu-Abadie N., Gouazé V., Salvayre R., and Levade T. Ceramide in apoptosis signaling: relationship with oxidative stress. Free Radic Biol Med 31 (2001) 717-728
48. Sirotaa L., Shachama D., Punskyb I., and Bessler H. Ibuprofen affects pro-and anti-inflammatory cytokine production by mononuclear cells of preterm newborns. Biol Neonate 79 (2001) 103-108
49. Khair O.A., Devalia J.L., Abdelaziz M.M., Sapsford R.J., Tarraf H., and Davies R.J. Effect of Haemophilus influenzae endotoxin on the synthesis of IL-6, IL-8, TNF-alpha and expression of ICAM-1 in cultured human bronchial epithelial cells. Eur Respir J 7 (1994) 2109-2116
50. Siddik Z.H. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22 (2003) 7265-7279
51. Ip Y.T., and Davis R.J. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr Opin Cell Biol 10 (1998) 205-219
52. Muldoon L.L., Walker-Rosenfeld S.L., Hale C., Purcell S.E., Bennett L.C., and Neuwelt E.A. Rescue from enhanced alkylator-induced cell death with low molecular weight sulfur-containing chemoprotection. J Pharmacol Exp Ther 296 (2001) 797-805
53. Zafarullah M., Li W.Q., Sylvester J., and Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 60 (2003) 6-20
54. Li W.Q., Dehnade F., and Zafarullah M. Thiol antioxidant, N-acetylcysteine, activates extracellular signal-regulated kinase signaling pathway in articular chondrocytes. Biochem Biophys Res Commun 275 (2000) 789-794
55. Chen Y., Zhou G., and Tan T.-H. c-Jun N-terminal kinase mediates apoptotic signaling induced by N-(4-Hydroxyphenyl) retinamide. Mol Pharmacol 56 (1999) 1271-1279
56. Harris J.F., Fisher M.J., Hotchkiss J.R., Monia B.P., Randell S.H., Harkema J.R., et al. Bcl-2 sustains increased mucuous and epithelial cell numbers in metaplasic airway epithelium. Am J Respir Crit Care 171 (2005) 764-772
57. Pyne S., and Pyne N.J. Sphingosine 1-phosphate signalling in mammalian cells. Biochem J 349 (2000) 385-402
58. Hail Jr. N., and Lotan R. Mitochondrial respiration is uniquely associated with prooxidant apoptotic effects of N-(4-hydroxyphenyl) retinamide. J Biol Chem 276 (2001) 45614-45621
59. Bardales R.H., Xie S.S., Schaefer R.F., and Hsu S.M. Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am J Pathol 149 (1997) 845-852
60. Polunovsky V.A., Chen B., Henke C., Snover D., and Wendt C. Role of mesenchymal cell death in lung remodeling after injury. J Clin Invest 92 (1993) 388-397
61. Henke M.O., Renner A., Huber R.M., Seeds M.C., and Rubin B.K. MUC5AC and MUC5B mucins are decreased in cystic fibrosis airway secretions. Am J Respir Cell Mol Biol 31 (2004) 86-91
62. Ramphal R., and Arora S.K. Recognition of mucin components by Pseudomonas aeruginosa. Glycoconj J 18 (2001) 709-713
63. E.S. Kim. Fenretinide and lonafarnib in treating patients with advanced or recurrent head and neck cancer. In: (Online). http://www.clinicaltrials.gov/ct/show/NCT00103090. National Institutes of Health (NIH) (2005), October 26.